ConductScience.org, home

Paper34864950

Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network.

Bukkems VE and 13 others. Clin Infect Dis, 2022. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network. Papers, record 34864950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34864950

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2025-01-03
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bukkems VEVera Ehttps://orcid.org/0000-0002-7644-1123
2Necsoi CCoca
3Hidalgo Tenorio CCarmen
4Garcia CCoral
5Alba Alejandre IIrene
6Weiss FFabian
7Lambert JSJohn S
8van Hulzen AAstrid
9Richel OOlivier
10Te Brake LHMLindsey H M
11van der Meulen EEric
12Burger DDavid
13Konopnicki DDeborah
14Colbers AAngelahttps://orcid.org/0000-0002-5613-2518

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-HIV AgentsMajor topic
HIV InfectionsMajor topic
Adenine
Alanine
Female
HIV
Humans
Pregnancy
Pregnant People
Tenofovir

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116176115Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.Clin Pharmacokinet2005https://conductscience.org/library/papers/16176115PubMed
225959631Pharmacokinetics of tenofovir during pregnancy and postpartum.HIV Med2015https://conductscience.org/library/papers/25959631PubMed
326640223Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus.Antiviral Res2016https://conductscience.org/library/papers/26640223PubMed
428971607Lack of clinically important PK interaction between coformulated ledipasvir/sofosbuvir and rilpivirine/emtricitabine/tenofovir alafenamide.Pharmacol Res Perspect2017https://conductscience.org/library/papers/28971607PubMed
523807155Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults.J Acquir Immune Defic Syndr2013https://conductscience.org/library/papers/23807155PubMed
633252495Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV.AIDS2021https://conductscience.org/library/papers/33252495PubMed
730783649Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus.Clin Infect Dis2019https://conductscience.org/library/papers/30783649PubMed
829435666Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications.Pharm Res2018https://conductscience.org/library/papers/29435666PubMed
924872136Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study.J Acquir Immune Defic Syndr2014https://conductscience.org/library/papers/24872136PubMed
1021089008Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients.Am J Perinatol2011https://conductscience.org/library/papers/21089008PubMed
1123169329The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.AIDS2013https://conductscience.org/library/papers/23169329PubMed
1225890673
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Lancet2015https://conductscience.org/library/papers/25890673PubMed
1315855512
Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue.
Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15855512PubMed
1432330231
Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network.
Clin Infect Dis2020https://conductscience.org/library/papers/32330231PubMed
1530815689Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide.J Antimicrob Chemother2019https://conductscience.org/library/papers/30815689PubMed
1623601190A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants.BMC Pediatr2013https://conductscience.org/library/papers/23601190PubMed
1724508897Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults.J Antimicrob Chemother2014https://conductscience.org/library/papers/24508897PubMed
1822850510Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitro.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22850510PubMed
1933812487
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet2021https://conductscience.org/library/papers/33812487PubMed
2032115202Drugs in pregnancy: Pharmacologic and physiologic changes that affect clinical care.Semin Perinatol2020https://conductscience.org/library/papers/32115202PubMed

See all 27 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42687587Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum.J Clin Pharmacol2026https://conductscience.org/library/papers/42687587PubMed
42090286Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy.J Antimicrob Chemother2026https://conductscience.org/library/papers/42090286PubMed
41222898
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum.
Clin Pharmacokinet2026https://conductscience.org/library/papers/41222898PubMed
40413716An Exploratory Pharmacogenetic Pilot Study of Two Reverse Transcriptase Inhibitors, Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate.Drugs R D2025https://conductscience.org/library/papers/40413716PubMed
39487018Care of Pregnant Women Living with Human Immunodeficiency Virus.Clin Perinatol2024https://conductscience.org/library/papers/39487018PubMed
39196368Preventing perinatal HIV acquisition; current gaps and future perspectives.Curr Opin HIV AIDS2024https://conductscience.org/library/papers/39196368PubMed
37612306Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection.Expert Rev Clin Pharmacol2023https://conductscience.org/library/papers/37612306PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
BCRP1644079PubTator's text mininghttps://conductscience.org/library/genes/644079NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CTSA5476PubTator's text mininghttps://conductscience.org/library/genes/5476NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34864950

GET https://conductscience.org/api/papers/v1/34864950/references?page=2